BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

253 related articles for article (PubMed ID: 32303236)

  • 1. Brain metastases treated with hypofractionated stereotactic radiotherapy: 8 years experience after Cyberknife installation.
    Mengue L; Bertaut A; Ngo Mbus L; Doré M; Ayadi M; Clément-Colmou K; Claude L; Carrie C; Laude C; Tanguy R; Blanc J; Sunyach MP
    Radiat Oncol; 2020 Apr; 15(1):82. PubMed ID: 32303236
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Single-fraction radiosurgery versus fractionated stereotactic radiotherapy in patients with brain metastases: a comparative study.
    Loo M; Pin Y; Thierry A; Clavier JB
    Clin Exp Metastasis; 2020 Jun; 37(3):425-434. PubMed ID: 32185576
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Radiosurgery or hypofractionated stereotactic radiotherapy for brain metastases from radioresistant primaries (melanoma and renal cancer).
    Lesueur P; Lequesne J; Barraux V; Kao W; Geffrelot J; Grellard JM; Habrand JL; Emery E; Marie B; Thariat J; Stefan D
    Radiat Oncol; 2018 Jul; 13(1):138. PubMed ID: 30055640
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Risk of radiation necrosis after hypofractionated stereotactic radiotherapy (HFSRT) for brain metastases: a single center retrospective study.
    Di Perri D; Tanguy R; Malet C; Robert A; Sunyach MP
    J Neurooncol; 2020 Sep; 149(3):447-453. PubMed ID: 32979130
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy and safety of hypofractionated stereotactic radiotherapy for brain metastases using three fractions: A single-centre retrospective study.
    Vigneau E; Jacquemin J; Benadon B; Dat Nguyen T; Marchand-Créty C
    Cancer Radiother; 2021 Dec; 25(8):763-770. PubMed ID: 34083125
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Retrospective analysis of hypofractionated stereotactic radiotherapy for tumors larger than 2 cm.
    Koide Y; Tomita N; Adachi S; Tanaka H; Tachibana H; Kodaira T
    Nagoya J Med Sci; 2019 Aug; 81(3):397-406. PubMed ID: 31579330
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hypofractionated Stereotactic Radiation Therapy to the Resection Bed for Intracranial Metastases.
    Keller A; Doré M; Cebula H; Thillays F; Proust F; Darié I; Martin SA; Delpon G; Lefebvre F; Noël G; Antoni D
    Int J Radiat Oncol Biol Phys; 2017 Dec; 99(5):1179-1189. PubMed ID: 28974415
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Postoperative stereotactic radiosurgery and hypofractionated radiotherapy for brain metastases using Gamma Knife and CyberKnife: a dual-center analysis.
    Kübler J; Wester-Ebbinghaus M; Wenz F; Stieler F; Bathen B; Mai SK; Wolff R; Hänggi D; Blanck O; Giordano FA
    J Neurosurg Sci; 2024 Feb; 68(1):22-30. PubMed ID: 32031357
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Normofractionated stereotactic radiotherapy versus CyberKnife-based hypofractionation in skull base meningioma: a German and Italian pooled cohort analysis.
    Alfredo C; Carolin S; Güliz A; Anne K; Antonio P; Alberto C; Stefano P; Antonino G; Harun B; Markus K; Franziska M; Phuong N; Franziska L; Peter V; Volker B; David K
    Radiat Oncol; 2019 Nov; 14(1):201. PubMed ID: 31718650
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hypofractionated Stereotactic Radiotherapy for Patients with Intracranial Meningiomas: impact of radiotherapy regimen on local control.
    Meniai-Merzouki F; Bernier-Chastagner V; Geffrelot J; Tresch E; Lacornerie T; Coche-Dequeant B; Lartigau E; Pasquier D
    Sci Rep; 2018 Sep; 8(1):13666. PubMed ID: 30209337
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Brain metastases treated with radiosurgery or hypofractionated stereotactic radiotherapy: outcomes and predictors of survival.
    Sallabanda M; García-Berrocal MI; Romero J; García-Jarabo V; Expósito MJ; Rincón DF; Zapata I; Magallón MR
    Clin Transl Oncol; 2020 Oct; 22(10):1809-1817. PubMed ID: 32124243
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hypofractionated stereotactic radiotherapy (HFSRT) versus single fraction stereotactic radiosurgery (SRS) to the resection cavity of brain metastases after surgical resection (SATURNUS): study protocol for a randomized phase III trial.
    Waltenberger M; Bernhardt D; Diehl C; Gempt J; Meyer B; Straube C; Wiestler B; Wilkens JJ; Zimmer C; Combs SE
    BMC Cancer; 2023 Jul; 23(1):709. PubMed ID: 37516835
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HFSRT of the resection cavity in patients with brain metastases.
    Specht HM; Kessel KA; Oechsner M; Meyer B; Zimmer C; Combs SE
    Strahlenther Onkol; 2016 Jun; 192(6):368-76. PubMed ID: 26964777
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of 2-staged stereotactic radiosurgery for treatment of brain metastases ≥ 2 cm.
    Angelov L; Mohammadi AM; Bennett EE; Abbassy M; Elson P; Chao ST; Montgomery JS; Habboub G; Vogelbaum MA; Suh JH; Murphy ES; Ahluwalia MS; Nagel SJ; Barnett GH
    J Neurosurg; 2018 Aug; 129(2):366-382. PubMed ID: 28937324
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of regular magnetic resonance imaging follow-up after stereotactic radiotherapy to the surgical cavity in patients with one to three brain metastases.
    Bachmann N; Leiser D; Ermis E; Vulcu S; Schucht P; Raabe A; Aebersold DM; Herrmann E
    Radiat Oncol; 2019 Mar; 14(1):45. PubMed ID: 30871597
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hypofractionated stereotactic radiotherapy of limited brain metastases: a single-centre individualized treatment approach.
    Märtens B; Janssen S; Werner M; Frühauf J; Christiansen H; Bremer M; Steinmann D
    BMC Cancer; 2012 Oct; 12():497. PubMed ID: 23098039
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Local control and possibility of tailored salvage after hypofractionated stereotactic radiotherapy of the cavity after brain metastases resection.
    Bilger A; Bretzinger E; Fennell J; Nieder C; Lorenz H; Oehlke O; Grosu AL; Specht HM; Combs SE
    Cancer Med; 2018 Jun; 7(6):2350-2359. PubMed ID: 29745035
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluatıon of hypofractıonated stereotactıc radıotherapy (HFSRT) to the resectıon cavıty after surgıcal resectıon of braın metastases: A sıngle center experıence.
    Dincoglan F; Sager O; Uysal B; Demiral S; Gamsiz H; Gündem E; Elcim Y; Dirican B; Beyzadeoglu M
    Indian J Cancer; 2019; 56(3):202-206. PubMed ID: 31389381
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intracranial meningioma: Experience with stereotactic radiotherapy.
    Ragos V; Yazici O; Guzle Adas Y; Kekilli E; Calikoglu T; Bedri Altundag M; Riza Ucer A; Ertas G; Durmus Duzgun S; Ozbagi K; Demirkasimoglu A; Demir E; Aslan B; Kaya B
    J BUON; 2018; 23(4):1169-1173. PubMed ID: 30358227
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Five fraction stereotactic radiotherapy after brain metastasectomy: a single-institution experience and literature review.
    Rogers S; Stauffer A; Lomax N; Alonso S; Eberle B; Gomez Ordoñez S; Lazeroms T; Kessler E; Brendel M; Schwyzer L; Riesterer O
    J Neurooncol; 2021 Oct; 155(1):35-43. PubMed ID: 34546498
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.